Diepenbroek, C
Li G, Simon MJ, Cancel LM, Shi Z-D, Ji X, Tarbell JM, et al
Research on glycocalyx protectants (such as phillyrin and sphingosine-1-phosphate) is still in its early stages and relies on animal models and in vitro experiments [76, 121]
(2025) [40], were conducted in adults with obesity (typically BMI 30 kg/m 2 ), most of whom had comorbid type 2 diabetes and consistently excluded individuals with active, severe, or unstable psychiatric disorders
By taking these factors into account, healthcare teams can more comprehensively assess the effectiveness of individualized treatments, thereby providing enhanced care for patients